Value of pathological grading in prediction of renal survival in IgA nephropathy

Nephrology

Volumn 2, Issue 2, 1996, Pages 107-117

  Yagame, Mitsunori ^a   Suzuki, Daisuke ^a   Jinde, Kiichiro ^a   Saotome, Noboru ^a   Murakami, Rika ^a   Asakura, Kumiko ^a   Nakashima, Risin ^a   Kashem, Abul ^a   Yano, Naohiro ^a   Endoh, Masayuki ^a   Nomoto, Yasuo ^a   Sakai, Hideto ^a   Tomino, Yasuhiko ^b  

^a TOKAI UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

IgA nephropathy; Pathological grading; Reciprocal of serum creatinine; Renal survival rate

Indexed keywords

EID: 0001658318     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1996.tb00073.x     Document Type: Article

References (67)

1. Berger J, Hinglais N. Les dépôts intercapillaires d'IgA-IgG. J. Urol. Nephrol. 1968; 74: 694-5.
2. Berger J. IgA glomerular deposits in renal disease. Transplant Proc. 1969; 1: 939-44.
3. Yokoska H, Nagase M, Maeda T, Koide K. Mesangial IgA glomerulonephritis: Clinicopathological study of 85 cases. Contri. Nephrol. 1978; 9: 101-10.
4. Abe T, Kida H, Yoshimura M, Yokoyama H, Koshino Y, Tomosugi N, Hattori N. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy. Clin. Nephrol. 1986; 25: 37-41.
5. Payton CD, McLay A, Boulton Jones JM. Progressive IgA nephropathy: The role of hypertension. Nephrol. Dial. Transplant. 1988; 3: 138-42.
6. Rekola S, Bergstrand A, Bucht H. IgA nephropathy: A retrospective evaluation of prognostic indices in 176 patients. Scand. J. Urol. Nephrol. 1989; 23: 37-50.
7. Droz D, Kramar A, Nawar T, Noel LH. Primary IgA nephropathy: Prognostic factors. Contrib. Nephrol 1984; 40: 202-7.
8. Abe S, Amagasaki Y, Iyori S, Konishi K, Kato E, Sakaguchi H. Significance of tubulointerstitial lesions in biopsy specimens of giomerulonephritic patients. Am. J. Nephrol. 1989; 9: 30-7.
9. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q. J. Med. 1984; 53: 227-50.
10. D'Amico G, Colasanti G, Barbiano di Belgiojoso G et al. Long-term follow-up of IgA mesangial nephropathy: Clinico-histological study in 374 patients. Semin. Nephrol. 1987; 7: 355-8.
11. Johnston PA, Brown JS, Braumholtz DA, Davison AM, Clinicopathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy: A report from the MRC glomerulonephritis Registry. Q. J. Med. 1992; 84: 619-27.
12. Clarkson AR, Woodroffe AJ, Aarons I. IgA nephropathy in patients followed up for at least ten years. Semin. Nephrol. 1977; 7: 377-8.
13. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analysis. Am. J. Kidney Dis. 1990; 18: 12-19.
14. D'Amico G, Minetti L, Ponticelli C et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q. J. Med. 1986; 59: 363-78.
15. Ibels LS, Györy AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1944; 73: 79-102.
16. Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L. Natural history of IpA nephropathy in patients followed up for more than ten years in Spain. Semin. Nephrol. 1987; 7: 346-50.
17. Kawamura N, Murakami Y, Ohkoshi M et al. Modified open renal biopsy. Tokai. J. Exp. Clin. Med. 1980; 5: 23-7.
18. D'Amico G, Barbiano di Belgiojoso G, Imbasciati E et al. Idiopathic IgA mesangial nephropathy: Natural history. Contrib. Nephrol. 1984; 40: 208-13.
19. Droz D. Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib. Nephrol. 1976; 2: 150-7.
20. Woo KT, Edmondson RPS, Wu Ayt, Chiang GS, Pwee HS, Lim CH. The natural history of IgA nephritis in Singapore. Clin. Nephrol. 1986; 25: 15-21.
21. Nomoto Y, Tomino Y, Endoh M, Suga T, Miura M, Nomoto H, Sakai H. Modified open renal biopsy: Results in 934 patients. Nephron 1987; 45: 224-8.
22. Tomino Y, Sakai H, Endoh M, Kaneshige H, Nomoto Y. Detection of immune complexes in polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Clin. Immunol. Immunopathol. 1982; 24: 63-71.
23. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-81.
24. Cox DR. Regression models and life tables. J. R. Stat. Soc. (B) 1972; 34: 187-202.
25. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyana M, Tateno S. IgA nephropathy: Heterogeneous clinical pictures and steroid therapy in progressive cases. Semin. Nephrol. 1987; 7: 382-5.
26. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y. IgA nephropathy in Japanese children and adults: A comparative study of clinicopathological features. Am. J. Nephrol. 1990; 10: 191-7.
27. D'Amico G. Influence of clinical and historical features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am. J. Kidney Dis. 1982; 20: 315-23.
28. Gallo GR, Katafuchi R, Neelakantappa K, Baldwin DS. Prognostic pathological markers in IgA nephropathy. Am. J. Kidney Dis. 1988; 12: 562-5.
29. Imbasciati E, Colasanti G, Barbiano di Belgiojoso G et al. Long-term follow-up of IgA mesangial deposits glomerulonephritis. Proc. Eur. Dial. Transplant. Assoc. 1977; 14:472-7.
30. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S. Moderately proteinuric IgA nephropathy: Prognostic prediction of individual clinical courses and steroid therapy in progressive cases. Nephron 1989; 53: 250-6.
31. Mustonen J, Pasternack A, Helin H, Nikkaila M. Clinico-pathological correlations in a series of 143 patients with IgA glomerulonephritis. Am. J. Nephrol. 1985; 5: 150-7.
32. Ng WL, Loke SL, Yeung CK, Kwan S, Chan KW, Chan MK. Clinical and histopathological predictors of progressive disease in IgA nephropathy. Pathology 1986; 18: 29-34.
33. Nussenzveig I, Saldanha LR, Marcondes M. Primary mesangial IgA nephropathy in Sao Paulo, Brazil. Nephron 1989; 52: 198-9.
34. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin. Nephrol. 1992; 37: 235-8.
35. van der Peet J, Arisz L, Rrentjens JRH, Marrink J, Hoedemacker Ph. The clinical course of IgA nephropathy in adults. Clin. Nephrol. 1977; 8: 335-40.
36. D'Amico G, Imbasciati E, Barbiano di Belgiojoso G et al. Idiopathic IgA mesangial nephropathy: Clinical and histological study of 374 patients. Medicine (Baltimore) 1985; 64: 49-60.
37. Schmekel B, Svalander C, Bucht H, Westberg NG. Mesangial IgA glomerulonephritis in adults: Clinical and histopathological observations. Acta Med. Scand. 1981; 210: 363-72.
38. Boyce NW, Holdsworth SR, Thomson NM, Atkins RC. Clinicopathological association in mesangial IgA nephropathy. Am. J. Nephrol 1986; 6: 246-52.
39. Chida Y, Tomura S, Takeuchi J. Renal survival rate of IgA nephropathy. Nephron 1985; 40: 189-94.
40. Bennett WM, Walker RG, Kincaid-Smith P. Renal cortical interstitial volume in mesangial IgA nephropathy: Dissociation from creatinine clearance in serially biopsied patients. Lab. Invest. 1982; 47:330-5.
41. Bogenschutz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gartner HV. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am. J. Nephrol. 1990; 10: 137-47.
42. Shigematsu H, Kohayashi Y, Tateno S, Hiki Y, Kuwao S. The significance of tubulointerstitial nephritis in IgA nephritis. Japn. J. Nephrol. 1994; 36: 25-32.
43. Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese. Clin. Nephrol. 1987; 28: 118-24.
44. Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: A morphological and clinical study. Clin. Nephrol. 1987; 27: 131-40.
45. Noël LH, Droz D, Gascon M, Berger J. Primary IgA nephropathy: From the first described cases to the present. Semin. Nephrol. 1987; 7:351-4.
46. Rekola S, Bergstrand A, Bucht H. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int. 1991; 40: 1050-4.
47. Tateno S, Kobayashi Y. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy. Nephron 1987; 46: 28-33.
48. Kobayashi M, Koyama A, Yamagata K, Yamaguchi N, Narita M, Shigematsu H. Significance of deposits and abnormalities of the glomerular basement membrane in tissue injury accompanying IgA nephropathy. Japn. J. Nephrol. 1992; 34: 47-56.
49. Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am. J. Kidney Dis. 1987; 9: 404-9.
50. Alamartine E, Sabatier JC, Berthoux FC. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: Value of quantitative scoring and approach to final prognosis. Clin. Nephrol. 1990; 34: 45-51.
51. Sakai H, Abe K, Kobayashi Y et al. Clinical guidelines of IgA nephropathy. Jpn. J. Nephrol. 1995; 37: 417-21.
52. Nomoto Y, Endoh M, Suga T, Miura M, Sakai H. Minimum requirements for renal biopsy size for patients with IgA nephropathy. Nephron 1992; 60: 171-5.
53. Mitch WE, Walser M, Buffington GA, Leman J Jr et al. A simple method of estimating progression of chronic renal failure. Lancet 1976; ii: 1326-8.
54. Armitage P, Berry G. Survival analysis. In: Armitage P (ed.) Statistical methods in medical research, 3rd edition, Blackwell Science Oxford, 1994; 469-92.
55. Roodnat JL, van Stiphout WAHJ, Rosendaal FR, van Es LA, Vandenbroucke JP. What do we really know about the long-term prognosis of IgA nephropathy? J. Nephrol. 1991; 3: 145-51.
56. Bailey RR, Lynn KL, Robson RA, Smith AH, Wells JE. Long-term follow-up of patients with IgA nephropathy. N.Z. Med. J. 1994; 27: 142-4.
57. D'Amico G. The natural history of IgA disease. Contrib. Nephrol. 1989; 70: 116-20.
58. D'Amico G, Vandemia F. Hypertension in IgA nephropathy. Contrib. Nephrol. 1987; 54: 113-18.
59. D'Amico G. Clinical features and natural history in adults with IgA nephropathy. Am. J. Kidney Dis. 1988; 12: 353-7.
60. Neelakantappa K, Gallo GR, Baldwin DS. Proteinuria in IgA nephropathy. Kidney Int. 1988; 33: 716-21.
61. Woo KT, Chiang GSC, Lau YK, Lim CH. IgA nephritis in Singapore: Clinical, prognostic indices, and treatment. Semin. Nephrol. 1987; 7: 379-81.
62. Beukhof JR, Kardaun O, Schaafsma W et al. Toward individual prognosis of IgA nephropathy. Kidney Int. 1986; 29: 549-56.
63. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH. IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am. J. Kidney Dis. 1984; 4: 192-200.
64. Lai KN, Lai FM, Vallance-Owen J. The clinical use of serum beta-2 microglobulin and fractional beta-2-microglobulin excretion in IgA nephropathy. Clin. Nephrol. 1986; 25: 260-5.
65. Woo KT, Lau YK, Yap HK, Lee GS, Chiang GS, Lim CH. Protein selectivity: A prognostic index in IgA nephritis. Nephron 1989; 52: 300-6.
66. Clarkson AR, Seymour AE, Thompson AJ, Haynes WDG, Chan YL, Jackson B. IgA nephropathy: A syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin. Nephrol 1977; 8: 459-71.
67. Hogg RJ, Silva FG. IgA nephropathy: Natural history and prognostic indices in children. Contrib. Nephrol. 1984; 40: 214-21.